p.90 抽出テキスト

to the Japanese diet and all-cause and cause-specific mortality: the Japan Public Health Center-based Prospective Study. Eur J Nutr 2021; 60: 1327-1336. PMID: 32676701 384. Murai U, Yamagishi K, Sata M, et al. Seaweed intake and risk of cardiovascular disease: the Japan Public Health Center-based Prospective (JPHC) Study. Am J Clin Nutr 2019; 110: 1449-1455. PMID: 31518387 385. Kishida R, Yamagishi K, Muraki I, et al. Frequency of seaweed intake and its association with cardiovascular disease mortality: The JACC Study. J Atheroscler Thromb 2020; 27: 1340-1347. PMID: 32132341 386. Chichibu H, Yamagishi K, Kishida R, et al. Seaweed intake and risk of cardiovascular disease: The Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb 2021; 28: 1298-1306. PMID: 33597328 387. Khan TA, Tayyiba M, Agarwal A, et al. Relation of total sugars, sucrose, fructose, and added sugars with the risk of cardiovascular disease: A systematic review and dose-response meta-analysis of prospective cohort studies. Mayo Clin Proc 2019; 94: 2399-2414. PMID: 31806098 388. Micha R, Shulkin ML, Peñalvo JL, et al. Etiologic effects and optimal intakes of foods and nutrients for risk of cardiovascular diseases and diabetes: Systematic reviews and meta-analyses from the Nutrition and Chronic Diseases Expert Group (NutriCoDE). PLoS One 2017; 12: e0175149. PMID: 28448503 389. Auerbach BJ, Dibey S, Vallila-Buchman P, et al. Review of 100% fruit juice and chronic health conditions: implications for sugar-sweetened beverage policy. Adv Nutr 2018; 9: 78-85. PMID: 29659683 390. Collin LJ, Judd S, Safford M, et al. Association of sugary beverage consumption with mortality risk in us adults: A secondary analysis of data from the  REGARDS Study. JAMA Netw Open 2019; 2: e193121. PMID: 31099861 391. de Koning L, Malik VS, Kellogg MD, et al. Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation 2012; 125: 1735-1741. PMID: 22412070 392. Xi B, Huang Y, Reilly KH, et al. Sugar-sweetened beverages and risk of hypertension and CVD: a dose-response meta-analysis. Br J Nutr 2015; 113: 709-717. PMID: 25735740 393. Imamura F, O’Connor L, Ye Z, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. Br J Sports Med 2016; 50: 496-504. PMID: 27044603 394. Eshak ES, Iso H, Kokubo Y, et al. Soft drink intake in relation to incident ischemic heart disease, stroke, and stroke subtypes in Japanese men and women: the Japan Public Health Centre-based study cohort I. Am J Clin Nutr 2012; 96: 1390-1397. PMID: 23076619 395. Chiavaroli L, de Souza RJ, Ha V, et al. Effect of fructose on established lipid targets: A systematic review and meta-analysis of controlled feeding trials. J Am Heart Assoc 2015; 4: e001700. PMID: 26358358 396. David Wang D, Sievenpiper JL, de Souza RJ, et al. Effect of fructose on postprandial triglycerides: A systematic review and meta-analysis of controlled feeding trials. Atherosclerosis 2014; 232: 125-133. PMID: 24401226 397. Livesey G, Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr 2008; 88: 1419-1437. PMID: 18996880 398. Namazi N, Saneei P, Larijani B, et al. Soy product consumption and the risk of all-cause, cardiovascular and cancer mortality: a systematic review and meta-analysis of cohort studies. Food Funct 2018; 9: 2576-2588. PMID: 29666853 399. Yan Z, Zhang X, Li C, et al. Association between consumption of soy and risk of cardiovascular disease: A meta-analysis of observational studies. Eur J Prev Cardiol 2017; 24: 735-747. PMID: 28067550 400. Lou D, Li Y, Yan G, et al. Soy consumption with risk of coronary heart disease and stroke: a meta-analysis of observational studies. Neuroepidemiology 2016; 46: 242-252. PMID: 26974464 401. Nguyen HN, Miyagawa N, Miura K, et al. NIPPON DATA80 Research Group. Dietary tofu intake and long-term risk of death from stroke in a general population. Clin Nutr 2018; 37: 182-188. PMID: 27979412 402. Nagata C, Wada K, Tamura T, et al. Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: the Takayama study. Am J Clin Nutr 2017; 105: 426-431. PMID: 27927636 403. Anderson JW, Bush HM. Soy protein effects on serum lipoproteins: a

quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr 2011; 30: 79-91. PMID: 21730216 404. Blanco Mejia S, Messina M, Li SS, et al. A meta-analysis of 46 stud-

ies identified by the FDA emonstrates that soy protein decreases circulating LDL and total cholesterol concentrations in adults. J Nutr 2019; 149: 968-981. PMID: 31006811 405. Tokede OA, Onabanjo TA, Yansane A, et al. Soya products and serum lipids: a meta-analysis of randomised controlled trials. Br J Nutr 2015; 114: 831-843. PMID: 26268987 406. Eslami O, Shidfar F. Soy milk: A functional beverage with hypocholesterolemic effects? A systematic review of randomized controlled trials. Complement Ther Med 2019; 42: 82-88. PMID: 30670286 407. Weggemans RM, Trautwein EA. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr 2003; 57: 940-946. PMID: 12879088 408. Aune D, Keum N, Giovannucci E, et al. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies. BMC Med 2016; 14: 207. PMID: 27916000 409. Aune D. Plant Foods, Antioxidant Biomarkers, and the Risk of Cardiovascular Disease, Cancer, and Mortality: A Review of the Evidence. Adv Nutr 2019; 10 Suppl: S404-S421. PMID: 31728499 410. Brown RC, Gray AR, Tey SL, et al. Associations between Nut Consumption and Health Vary between Omnivores, Vegetarians, and Vegans. Nutrients 2017; 9: 1219. PMID: 29113145 411. Chen GC, Zhang R, Martínez-González MA, et al. Nut consumption in relation to all-cause and cause-specific mortality: a meta-analysis 18 prospective studies. Food Funct 2017; 8: 3893-3905. PMID: 28875220 412. Grosso G, Yang J, Marventano S, et al. Nut consumption on all-cause, cardiovascular, and cancer mortality risk: a systematic review and meta-analysis of epidemiologic studies. Am J Clin Nutr 2015; 101: 783-793. PMID: 25833976 413. Mayhew AJ, de Souza RJ, Meyre D, et al. A systematic review and meta-analysis of nut consumption and incident risk of CVD and allcause mortality. Br J Nutr 2016; 115: 212-225. PMID: 26548503 414. Luo C, Zhang Y, Ding Y, et al. Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis. Am J Clin Nutr 2014; 100: 256-269. PMID: 24847854 415. Weng YQ, Yao J, Guo ML, et al. Association between nut consumption and coronary heart disease: a meta-analysis. Coron Artery Dis 2016; 27: 227-232. PMID: 26704188 416. Ma L, Wang F, Guo W, et al. Nut consumption and the risk of coronary artery disease: A dose-response meta-analysis of 13 prospective studies. Thromb Res 2014; 134: 790-794. PMID: 25047173 417. Becerra-Tomás N, Paz-Graniel I, Kendall CWC, et al. Nut consumption and incidence of cardiovascular diseases and cardiovascular disease mortality: a meta-analysis of prospective cohort studies. Nutr Rev 2019; 77: 691-709. PMID: 31361320 418. Sabaté J, Oda K, Ros E. Nut consumption and blood lipid levels: A pooled analysis of 25 intervention trials. Arch Intern Med 2010; 170: 821-827. PMID: 20458092 419. Tey SL, Brown RC, Chisholm AW, et al. Effects of different forms of hazelnuts on blood lipids and α-tocopherol concentrations in mildly hypercholesterolemic individuals. Eur J Clin Nutr 2011; 65: 117-124. PMID: 20877394 420. Tey SL, Delahunty C, Gray A, et al. Effects of regular consumption of different forms of almonds and hazelnuts on acceptance and blood lipids. Eur J Nutr 2015; 54: 483-487. PMID: 25433502 421. Wu L, Piotrowski K, Rau T, et al. Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: A randomized controlled cross-over clinical trial. Metabolism 2014; 63: 382-391. PMID: 24360749 422. Banel DK, Hu FB. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am J Clin Nutr 2009; 90: 56-63. PMID: 19458020 423. Altamimi M, Zidan S, Badrasawi M. Effect of Tree Nuts Consumption on Serum Lipid Profile in Hyperlipidemic Individuals: A Systematic Review. Nutr Metab Insights 2020; 13: 1178638820926521. PMID: 32595280 424. Sheerah HA, Eshak ES, Cui R, et al. Relationship Between Dietary Vitamin D and Deaths From Stroke and Coronary Heart Disease: The Japan Collaborative Cohort Study. Stroke 2018; 49: 454-457. PMID: 29311267 425. Shi H, Chen H, Zhang Y, et al. 25-Hydroxyvitamin D level, vitamin D intake, and risk of stroke: A dose-response meta-analysis. Clin Nutr 2020; 39: 2025-2034. PMID: 31530422 426. Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010; 65: 225-236. PMID: 20031348 427. Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular